Pea power: Plant-Based drink may cut feeding tube need in cancer patients
NCT ID NCT05115760
First seen Jun 27, 2026 · Last updated Jul 17, 2026 · Updated 1 time
Summary
This study tests whether a pea protein nutritional drink can reduce the need for feeding tubes in people with head and neck cancer undergoing chemoradiation. About 57 adults with locally advanced cancer will drink the supplement as a meal replacement. The goal is to see if it helps maintain nutrition and lowers the rate of feeding tube placement, which can cause long-term swallowing problems.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- pea protein oral nutrition supplement (Kate Farms Standard 1.4 and 1.0)
- What this could lead to
- If it works, this could offer a simple, plant-based nutritional drink that helps patients avoid feeding tubes and maintain better swallowing function during cancer treatment.
- What could go wrong
- This is a small early-phase trial with only 57 participants, so results may not apply to everyone. The supplement may not prevent feeding tube placement in all cases, and some patients may still need a tube.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOCALLY ADVANCED HEAD AND NECK CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of California at Los Angeles
Los Angeles, California, 90095, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.